Kits Eyecare Ltd.
KTYCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $159,338 | $120,510 | $91,639 | $82,403 |
| % Growth | 32.2% | 31.5% | 11.2% | – |
| Cost of Goods Sold | $105,693 | $79,718 | $62,392 | $61,512 |
| Gross Profit | $53,645 | $40,792 | $29,247 | $20,891 |
| % Margin | 33.7% | 33.8% | 31.9% | 25.4% |
| R&D Expenses | $0 | $817 | $681 | $817 |
| G&A Expenses | $10,330 | $8,044 | $11,904 | $20,037 |
| SG&A Expenses | $32,088 | $24,909 | $24,025 | $35,559 |
| Sales & Mktg Exp. | $21,758 | $16,865 | $12,121 | $15,522 |
| Other Operating Expenses | $16,131 | $14,139 | $9,574 | $350 |
| Operating Expenses | $48,219 | $43,174 | $35,943 | $37,936 |
| Operating Income | $5,426 | -$1,432 | -$4,352 | -$17,045 |
| % Margin | 3.4% | -1.2% | -4.7% | -20.7% |
| Other Income/Exp. Net | -$975 | -$1,459 | -$1,524 | -$1,798 |
| Pre-Tax Income | $4,451 | -$2,891 | -$5,876 | -$18,843 |
| Tax Expense | $1,335 | -$676 | -$1,324 | -$4,226 |
| Net Income | $3,116 | -$2,215 | -$4,552 | -$14,617 |
| % Margin | 2% | -1.8% | -5% | -17.7% |
| EPS | 0.099 | -0.071 | -0.15 | -0.47 |
| % Growth | 240.1% | 52.9% | 68.1% | – |
| EPS Diluted | 0.092 | -0.071 | -0.15 | -0.47 |
| Weighted Avg Shares Out | 31,515 | 31,394 | 30,347 | 31,156 |
| Weighted Avg Shares Out Dil | 33,754 | 31,394 | 31,274 | 31,156 |
| Supplemental Information | – | – | – | – |
| Interest Income | $580 | $585 | $107 | $67 |
| Interest Expense | $1,199 | $1,560 | $1,631 | $1,490 |
| Depreciation & Amortization | $2,662 | $3,189 | $2,350 | $2,377 |
| EBITDA | $8,312 | $1,858 | -$1,895 | -$14,976 |
| % Margin | 5.2% | 1.5% | -2.1% | -18.2% |